how could new treatment options improve outcomes in flt3-mutated aml?
Published 2 years ago • 921 plays • Length 11:06Download video MP4
Download video MP3
Similar videos
-
20:58
new findings and improved outcomes in the treatment of aml
-
9:24
how could new treatment combinations improve outcomes in tp53 mutant aml?
-
4:32
improving outcomes in flt3-mutated aml patients
-
6:46
how can venetoclax combinations improve outcome for flt3-mutant aml?
-
2:26
improving outcomes for flt3-mutated r/r aml
-
29:51
finding the key to better outcomes in flt3-mutated aml
-
1:54
dr. wang discusses treatment options for flt3-mutated aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
1:32
novel treatment combinations for flt3-mutated aml
-
5:50
is sorafenib the new standard maintenance treatment for flt3 mutant aml?
-
6:47
the 2021 treatment algorithm for flt3-mutated aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
1:28
patient-reported outcomes in flt3-mutated aml patients treated with gilteritinib plus azacitidine
-
3:36
the importance of the flt3 mutation in aml
-
2:54
quantum-first: association between flt3-itd-specific mrd clearance and survival in patients with aml
-
8:37
how can outcomes be improved in patients with molecularly-defined high-risk aml?
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
3:27
sorafenib vs placebo in treatment-naïve flt3-itd aml
-
1:50
mechanisms of gilteritinib resistance in flt3-mutated aml